Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: An indication for personalized medicine

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Liu, Mulin ^a   Xu, Aman ^b   Yuan, Xiao ^b   Zhang, Qiao ^a   Fang, Taotao ^a   Wang, Wenbin ^b   Li, Chenglong ^c  

^a BENGBU MEDICAL COLLEGE   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

CRC; miR 409 3p; NLK; Tumorigenesis

Indexed keywords

CELL PROTEIN; CHOLECYSTOKININ OCTAPEPTIDE; MICRORNA; MICRORNA 409; NLK PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN409 MICRORNA, HUMAN; NLK PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE;

3' UNTRANSLATED REGION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CANCER INHIBITION; CELL COUNT; CLONOGENESIS; COLON METASTASIS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MIDDLE AGED; MOUSE; NONHUMAN; ONCOGENESIS AND MALIGNANT TRANSFORMATION; PERSONALIZED MEDICINE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR AGGRESSIVENESS; TUMOR GROWTH; TUMOR INVASION; TUMOR VOLUME; WOUND HEALING; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CELL CLONE; CELL MOTION; CELL PROLIFERATION; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; PERITONEUM; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CLONE CELLS; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PERITONEUM; PRECISION MEDICINE; PROTEIN-SERINE-THREONINE KINASES; TUMOR BURDEN; WOUND HEALING;

EID: 84935857714     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0533-x     Document Type: Article

References (33)

1. Center MM, Jemal A, Ward E (2009) International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 18:1688-1694
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
3. Nadal C, Maurel J, Gascon P (2007) Is there a genetic signature for liver metastasis in colorectal cancer? World J Gastroenterol 13:5832-5844
4. O'Hara SP, Mott JL, Splinter PL, Gores GJ, LaRusso NF (2009) MicroRNAs: key modulators of posttranscriptional gene expression. Gastroenterology 136:17-25
5. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
6. Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, Meister M et al (2007) The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 67:1419-1423
7. Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127:679-695
8. Zheng B, Liang L, Huang S, Zha R, Liu L, Jia D et al (2012) MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene 31:4509-4516
9. Li C, Nie H, Wang M, Su L, Li J, Yu B et al (2012) MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Lett 320:189-197
10. Josson S, Gururajan M, Sung SY, Hu P, Shao C, Zhau HE et al (2014) Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis. Oncogene 34(21):2690-2699
11. Xu X, Chen H, Lin Y, Hu Z, Mao Y, Wu J et al (2013) MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met. Mol Cells 36:62-68
12. Wang S, Xiang J, Li Z, Lu S, Hu J, Gao X et al (2015) A plasma microRNA panel for early detection of colorectal cancer. Int J Cancer 136:152-161
13. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS (2004) Human MicroRNA targets. PLoS Biol 2:e363
14. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115:787-798
15. Kruger J, Rehmsmeier M (2006) RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 34:W451-W454
16. Betel D, Wilson M, Gabow A, Marks DS, Sander C (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36:D149-D153
17. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10:1507-1517
18. Breving K, Esquela-Kerscher A (2010) The complexities of microRNA regulation: mirandering around the rules. Int J Biochem Cell Biol 42:1316-1329
19. Wan L, Zhu L, Xu J, Lu B, Yang Y, Liu F et al (2014) MicroRNA-409-3p functions as a tumor suppressor in human lung adenocarcinoma by targeting c-Met. Cell Physiol Biochem 34:1273-1290
20. Brott BK, Pinsky BA, Erikson RL (1998) Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus. Proc Natl Acad Sci USA 95:963-968
21. Anastas JN, Moon RT (2013) WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13:11-26
22. Zhang Y, Peng C, Wu G, Wang Y, Liu R, Yang S et al (2011) Expression of NLK and its potential effect in ovarian cancer chemotherapy. Int J Gynecol Cancer 21:1380-1387
23. Cui G, Li Z, Shao B, Zhao L, Zhou Y, Lu T et al (2011) Clinical and biological significance of nemo-like kinase expression in glioma. J Clin Neurosci 18:271-275
24. Emami KH, Brown LG, Pitts TE, Sun X, Vessella RL, Corey E (2009) Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells. Prostate 69:1481-1492
25. Li M, Zhang S, Wang Z, Zhang B, Wu X, Weng H et al (2013) Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer. Tumour Biol 34:3995-4000
26. Jung KH, Kim JK, Noh JH, Eun JW, Bae HJ, Xie HJ et al (2010) Targeted disruption of nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma. J Cell Biochem 110:687-696
27. Dong JR, Guo N, Zhao JP, Liu PD, Feng HH, Li Y (2013) Inhibition of nemo-like kinase increases taxol sensitivity in laryngeal cancer. Asian Pac J Cancer Prev 14:7137-7141
28. Chen J, Han Y, Zhao X, Yang M, Liu B, Xi X et al (2015) Nemolike kinase expression predicts poor survival in colorectal cancer. Mol Med Rep 11:1181-1187
29. Kim HA, Koo BK, Cho JH, Kim YY, Seong J, Chang HJ et al (2012) Notch1 counteracts WNT/beta-catenin signaling through chromatin modification in colorectal cancer. J Clin Invest 122:3248-3259
30. Mack GS (2007) MicroRNA gets down to business. Nat Biotechnol 25:631-638
31. Manceau G, Imbeaud S, Thiebaut R, Liebaert F, Fontaine K, Rousseau F et al (2014) Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy. Clin Cancer Res 20:3338-3347
32. Milosevic J, Pandit K, Magister M, Rabinovich E, Ellwanger DC, Yu G et al (2012) Profibrotic role of miR-154 in pulmonary fibrosis. Am J Respir Cell Mol Biol 47:879-887
33. Tsai KW, Wu CW, Hu LY, Li SC, Liao YL, Lai CH et al (2011) Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Int J Cancer 129:2600-2610